These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

410 related items for PubMed ID: 20600326

  • 1. Murine bone marrow chimeras developing autoimmunity after CTLA-4-blockade show an expansion of T regulatory cells with an activated cytokine profile.
    De Somer L, Fevery S, Bullens DM, Rutgeerts O, Lenaerts C, Mathieu C, Boon L, Kasran A, Waer M, Billiau AD.
    Immunol Lett; 2010 Sep 06; 133(1):49-53. PubMed ID: 20600326
    [Abstract] [Full Text] [Related]

  • 2. CTLA-4 x Ig converts naive CD4+CD25- T cells into CD4+CD25+ regulatory T cells.
    Razmara M, Hilliard B, Ziarani AK, Chen YH, Tykocinski ML.
    Int Immunol; 2008 Apr 06; 20(4):471-83. PubMed ID: 18272926
    [Abstract] [Full Text] [Related]

  • 3. Endothelial cells augment the suppressive function of CD4+ CD25+ Foxp3+ regulatory T cells: involvement of programmed death-1 and IL-10.
    Bedke T, Pretsch L, Karakhanova S, Enk AH, Mahnke K.
    J Immunol; 2010 May 15; 184(10):5562-70. PubMed ID: 20382886
    [Abstract] [Full Text] [Related]

  • 4. In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity.
    Tsang J, Jiang S, Tanriver Y, Leung E, Lombardi G, Lechler RI.
    Int Immunopharmacol; 2006 Dec 20; 6(13-14):1883-8. PubMed ID: 17161341
    [Abstract] [Full Text] [Related]

  • 5. Systemic CTLA-4 blockade ameliorates glioma-induced changes to the CD4+ T cell compartment without affecting regulatory T-cell function.
    Fecci PE, Ochiai H, Mitchell DA, Grossi PM, Sweeney AE, Archer GE, Cummings T, Allison JP, Bigner DD, Sampson JH.
    Clin Cancer Res; 2007 Apr 01; 13(7):2158-67. PubMed ID: 17404100
    [Abstract] [Full Text] [Related]

  • 6. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
    Wang DW, Zhou RB, Yao YM, Zhu XM, Yin YM, Zhao GJ, Dong N, Sheng ZY.
    J Pharmacol Exp Ther; 2010 Dec 01; 335(3):553-61. PubMed ID: 20843956
    [Abstract] [Full Text] [Related]

  • 7. Systemic anti-CD25 monoclonal antibody administration safely enhances immunity in murine glioma without eliminating regulatory T cells.
    Fecci PE, Sweeney AE, Grossi PM, Nair SK, Learn CA, Mitchell DA, Cui X, Cummings TJ, Bigner DD, Gilboa E, Sampson JH.
    Clin Cancer Res; 2006 Jul 15; 12(14 Pt 1):4294-305. PubMed ID: 16857805
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus.
    Kuhn A, Beissert S, Krammer PH.
    Arch Dermatol Res; 2009 Jan 15; 301(1):71-81. PubMed ID: 18985367
    [Abstract] [Full Text] [Related]

  • 11. CTLA-4 blockade in murine bone marrow chimeras induces a host-derived antileukemic effect without graft-versus-host disease.
    Fevery S, Billiau AD, Sprangers B, Rutgeerts O, Lenaerts C, Goebels J, Landuyt W, Kasran A, Boon L, Sagaert X, De Wolf-Peeters C, Waer M, Vandenberghe P.
    Leukemia; 2007 Jul 15; 21(7):1451-9. PubMed ID: 17508005
    [Abstract] [Full Text] [Related]

  • 12. Insufficient increment of CD4+CD25+ regulatory T cells after stimulation in vitro with allergen in allergic asthma.
    Wang LH, Lin YH, Yang J, Guo W.
    Int Arch Allergy Immunol; 2009 Jul 15; 148(3):199-210. PubMed ID: 18849611
    [Abstract] [Full Text] [Related]

  • 13. The levels of CD4+CD25+ regulatory T cells in paediatric patients with allergic rhinitis and bronchial asthma.
    Lee JH, Yu HH, Wang LC, Yang YH, Lin YT, Chiang BL.
    Clin Exp Immunol; 2007 Apr 15; 148(1):53-63. PubMed ID: 17349011
    [Abstract] [Full Text] [Related]

  • 14. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
    Terzieva V, Popova D, Kicheva M, Todorova Y, Markova R, Martinova F, Elenkov I, Yankova M.
    Int Immunopharmacol; 2009 Jul 15; 9(7-8):831-6. PubMed ID: 19303058
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
    Pyzik M, Piccirillo CA.
    J Leukoc Biol; 2007 Aug 15; 82(2):335-46. PubMed ID: 17475784
    [Abstract] [Full Text] [Related]

  • 17. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
    Ahn JS, Krishnadas DK, Agrawal B.
    Int Immunol; 2007 Mar 15; 19(3):227-37. PubMed ID: 17289657
    [Abstract] [Full Text] [Related]

  • 18. Bcl-xL is required for the development of functional regulatory CD4 cells in lupus-afflicted mice following treatment with a tolerogenic peptide.
    Sharabi A, Lapter S, Mozes E.
    J Autoimmun; 2010 Mar 15; 34(2):87-95. PubMed ID: 19596183
    [Abstract] [Full Text] [Related]

  • 19. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
    He F, Chen Z, Xu S, Cai M, Wu M, Li H, Chen X.
    Surgery; 2009 Jun 15; 145(6):663-74. PubMed ID: 19486771
    [Abstract] [Full Text] [Related]

  • 20. Blockade of CTLA-4 decreases the generation of multifunctional memory CD4+ T cells in vivo.
    Rudolph M, Hebel K, Miyamura Y, Maverakis E, Brunner-Weinzierl MC.
    J Immunol; 2011 May 15; 186(10):5580-9. PubMed ID: 21478403
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.